PRICE T ROWE ASSOCIATES INC /MD/
Position in PRLD — Prelude Therapeutics Inc
CIK 80255
BALTIMORE, MD
Position in PRLD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$121,300
-$2,070,972 QoQ
Shares Held
22,758
-97.0% QoQ
Ownership
0.029%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#41
of 75 holders
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PRLD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,929,584,838 across 304 Biotechnology names. PRLD ranks #276 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | TWST |
Twist Bioscience Corp
|
3,634,652 | $373,932,997 |
All Filings in PRLD
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $121,300 | 22,758 | Shares | Defined | 2026-08-14 | |
| 2025-12-31 | $2,192,272 | 755,956 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,261,926 | 876,338 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $750,434 | 927,608 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $749,680 | 976,147 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,312,227 | 1,029,199 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,272,029 | 1,097,599 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,395,844 | 891,298 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $4,464,941 | 941,971 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $4,452,486 | 1,042,737 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $3,296,590 | 1,066,858 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,870,115 | 1,082,248 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,620,863 | 284,362 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,816,089 | 300,677 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,070,020 | 313,165 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,604,382 | 307,353 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,228,617 | 322,988 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $3,788,933 | 304,332 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $12,352,375 | 395,276 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $11,474,961 | 400,802 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $18,328,200 | 422,991 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $27,738,504 | 387,680 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $12,052,000 | 400,000 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||